Global Health Ltd. (MEDANTA) fundamentals
Global Health Ltd. is a listed company in Healthcare Services, part of the Healthcare sector, listed on the NSE as MEDANTA (ISIN INE474Q01031). This page carries its reported financials, balance sheet, cash flow, shareholding pattern and valuation ratios.
What Global Health Ltd. does
Global Health Limited (Medanta) is an India-based multi-specialty tertiary care provider in the North and East regions of India. Medanta delivers advanced, end-to-end healthcare in Delhi, Gurugram, Indore, Ranchi, Patna, and Lucknow through its network of approximately five hospitals. Medanta provides healthcare services in over 30 medical specialties and engages over 1,800 doctors. Its specialty treatments are in cardiac care, cancer care, neurosciences, orthopedics, renal care, liver transplants, oncology, bone marrow transplant, obstetrics and gynecology, chest surgery, lung transplant, pediatric care, ENT, head and neck surgery, and others. Its facilities and services include medicine delivery, lab tests & diagnostics, homecare services, health checkups, elder care, air ambulance, among others. Its subsidiaries include Global Health Patliputra Private Limited, Medanta Holdings Private Limited, and GHL Pharma & Diagnostic Private Limited.
Valuation and market data
| Last close | ₹1210.70 |
|---|---|
| Market capitalisation | ₹32,391 crore |
| Enterprise value | ₹33,557 crore |
| P/E (TTM) | 58.46 |
| Price to book | 8.13 |
| Price to sales (TTM) | 4.05 |
| Book value per share | ₹148.92 |
| Dividend yield | 4.13% |
| Sector | Healthcare |
| Industry | Healthcare Services |
| Listed since | Wed Nov 16 |
Annual results
| Period | Revenue | Profit before tax | Net profit | EPS |
|---|---|---|---|---|
| Mar 2026 | ₹4,509 crore | ₹715 crore | ₹554 crore | 20.71 |
| Mar 2025 | ₹3,771 crore | ₹647 crore | ₹481 crore | 17.92 |
| Mar 2024 | ₹3,350 crore | ₹627 crore | ₹478 crore | 17.80 |
| Mar 2023 | ₹2,759 crore | ₹449 crore | ₹326 crore | 12.58 |
| Mar 2022 | ₹2,206 crore | ₹281 crore | ₹196 crore | 7.78 |
Figures are as reported (consolidated), in ₹ crore.
Shareholding pattern
As of Sep 2026:
| Promoters | 33.0% |
|---|---|
| Foreign institutions (FII) | 9.9% |
| Mutual funds | 16.0% |
| Other domestic institutions | 1.0% |
| Retail and others | 40.1% |
More on BreakPoint
FundaX company research covers every listed company with reported financials. BreakPoint Pro adds the BreakPoint iQ score, the screener and the multibagger board.
Data is sourced from exchange filings and vendor feeds and is for research, not investment advice. Figures can be restated by the company after publication.